Skip to content

Xiaohua Zou

2 papers in the library · 11 citations · publishing 2024-2026

Papers

Sort Most recent Most cited

Targeting NMDAR2A in microglia: esketamine suppresses M1 polarization in BV2 cells.

Molecular Biology Reports October 22, 2026 Hui Li, Xiaoyuan Zhang, Yushan Luo et al.

Objective: Microglial polarization toward the M1 phenotype is a key contributor to the initiation and progression of neuroinflammatory diseases, primarily through the release of pro-inflammatory cytokines that exacerbate central nervous system-associated injury. Activation of N-methyl-D-aspartic acid receptors (NMDARs) is implicated in microglial overactivation and cytotoxicity. This study...

Esketamine improves cognitive function in sepsis-associated encephalopathy by inhibiting microglia-mediated neuroinflammation.

European Journal of Pharmacology November 15, 2024 Hui Li, Wen Hu, Zhen Wu et al. 11 citations

Microglia-mediated neuroinflammation is critical in the pathogenesis of sepsis-associated encephalopathy(SAE). Identifying the key factors that inhibit microglia-mediated neuroinflammation holds promise as a potential target for preventing and treating SAE. Esketamine, a non-competitive N-methyl-D-aspartate (NMDA) receptor antagonist, has been proposed to possess protective and therapeutic...